STANDARD BIOTOOLS INC. — Director's Dealing 2022

Dec 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-12-29

Reporting Person: Caligan Partners LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-29	Common Stock, $0.001 par value per share (Common Stock)	J	2868037	—	Disposed	8576799	Indirect

Footnotes

F1: This transaction represents an in-kind distribution by certain funds and accounts to which Caligan Partners LP ("Caligan") serves as the investment manager.

F2: The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.